<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01196754</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0079</org_study_id>
    <nct_id>NCT01196754</nct_id>
  </id_info>
  <brief_title>Pharmacokinetic of Sevoflurane During a 48h Sedation in Intensive Care Unit With AnaConDa®</brief_title>
  <acronym>Anaconda</acronym>
  <official_title>Pharmacokinetic of Sevoflurane During a 48h Sedation in ICU With AnaConDa®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Estaing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pharmacy, University Hospital Clermont-Fd, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      This is a prospective clinical monocentric study in ICU with sedated ventilated patients with
      sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of
      sevoflurane.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective clinical monocentric study in ICU with sedated ventilated patients with
      sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of
      sévoflurane and its metabolites (hydroxyfluroisopropanol, fluoride)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of plasmatic concentrations of sévoflurane at different times of a 48h sedation of sévoflurane.</measure>
    <time_frame>during 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determination of plasmatic concentrations of HFIP and fluoride at different times of a 48h sedation of sévoflurane. Determination of a pharmacokinetic model of sévoflurane.</measure>
    <time_frame>during 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <arm_group_label>sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients ventilated more than 48 h

          -  Stable respiratory and hemodynamic conditions

          -  Consent of patients or family

          -  Arterial line

        Exclusion Criteria:

          -  Acute kidney injury

          -  Obesity

          -  Sevoflurane anaphylaxia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Bourdeaux</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2010</study_first_submitted>
  <study_first_submitted_qc>September 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2010</study_first_posted>
  <last_update_submitted>September 7, 2010</last_update_submitted>
  <last_update_submitted_qc>September 7, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2010</last_update_posted>
  <responsible_party>
    <name_title>Patrick LACARIN</name_title>
    <organization>CHU Clermont-Ferrand</organization>
  </responsible_party>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Fluorides</keyword>
  <keyword>Sedation</keyword>
  <keyword>Adult patients with a predicted sedation more than 48 h</keyword>
  <keyword>Stable respiratory and hemodynamic conditions for SBT</keyword>
  <keyword>Consent of patients</keyword>
  <keyword>Arterial line</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

